Certolizumab is prescribed for:
- Rheumatoid arthritis
- Crohn's disease
- Psoriasis and psoriatic arthritis
- Ankylosing spondylitis
- Immunology and gastrointestinal conditions
Generic Name: Certolizumab Pegol
Brand Names: Cimzia
Certolizumab is a pegylated anti-TNF biologic for RA, Crohn's disease, psoriasis, and ankylosing spondylitis.
Certolizumab is prescribed for:
Common side effects:
Serious side effects (boxed warnings):
Certolizumab is a pegylated anti-TNF antibody fragment (lacks Fc portion).
The pegylation and lack of Fc region may result in:
Preferred TNF inhibitor during pregnancy due to minimal placental transfer.
For details, see MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Certolizumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.